Akoya Biosciences, Inc.

NasdaqGS:AKYA Stock Report

Market Cap: US$100.7m

Akoya Biosciences Balance Sheet Health

Financial Health criteria checks 3/6

Akoya Biosciences has a total shareholder equity of $32.7M and total debt of $75.5M, which brings its debt-to-equity ratio to 230.6%. Its total assets and total liabilities are $154.8M and $122.0M respectively.

Key information

230.6%

Debt to equity ratio

US$75.47m

Debt

Interest coverage ration/a
CashUS$61.58m
EquityUS$32.72m
Total liabilitiesUS$122.03m
Total assetsUS$154.75m

Recent financial health updates

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

May 29
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)

May 10
Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)

Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?

Feb 28
Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?

Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump

Nov 25
Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump

Akoya Biosciences Seeks Growth Despite Higher Operating Losses

May 30

Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 11
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Akoya Biosciences and AstraZeneca ink collaboration agreement

Jun 04

Financial Position Analysis

Short Term Liabilities: AKYA's short term assets ($101.8M) exceed its short term liabilities ($33.2M).

Long Term Liabilities: AKYA's short term assets ($101.8M) exceed its long term liabilities ($88.8M).


Debt to Equity History and Analysis

Debt Level: AKYA's net debt to equity ratio (42.5%) is considered high.

Reducing Debt: Insufficient data to determine if AKYA's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AKYA has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AKYA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.